United Therapeutics Affiliate Initiates First-Ever Gene-Therapy Trial For Pulmonary Arterial Hypertension

... Lung Rx, Inc., a wholly-owned subsidiary of United Therapeutics Corporation (Nasdaq: UTHR), announced that its Canadian affiliate, Northern Therapeutics, Inc., has commenced the first-ever human trial of a novel, cell-mediated gene therapy for the treatment of pulmonary arterial hypertension. The first patient in the trial received therapy at St. [click link for full article] ...